CERo Therapeutics Holdings - Warrants (13/02/2029) Profit Margin

As of the most recent data (March 2026), CEROW shows a profit margin of -Infinity%. That compares with -11.95% in the prior-year period — down Infinity% year over year. That is below the sector sector average of 19.69%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CEROW's profit margin is now -Infinity% (was -11.95%) — a Infinity% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CERo Therapeutics Holdings - Warrants (13/02/2029) is outperforming or lagging.

The its sector sector average profit margin is about 19.69%. CERo Therapeutics Holdings - Warrants (13/02/2029) is at -Infinity%, which is lower that average. That is roughly Infinity% below the sector mean. Use the comparison chart on this page to see how CEROW stacks up against individual peers as well.

That compares with -11.95% in the prior-year period — down Infinity% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare CERo Therapeutics Holdings - Warrants (13/02/2029) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has CERo Therapeutics Holdings - Warrants (13/02/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -Infinity%) with ownership activity and broader fundamentals.